411 related articles for article (PubMed ID: 18347541)
1. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
Liu YP; Li Z; Nador RG; Strober S
Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
[TBL] [Abstract][Full Text] [Related]
2. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
Azuma E; Yamamoto H; Kaplan J
J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
[TBL] [Abstract][Full Text] [Related]
3. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance.
Dennert G; Anderson CG; Warner J
J Immunol; 1985 Dec; 135(6):3729-34. PubMed ID: 3905963
[TBL] [Abstract][Full Text] [Related]
4. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
Dennert G; Anderson CG; Warner J
J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance.
Cobbold SP; Martin G; Qin S; Waldmann H
Nature; 1986 Sep 11-17; 323(6084):164-6. PubMed ID: 3528866
[TBL] [Abstract][Full Text] [Related]
6. New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantation.
Slavin S; Or R; Naparstek E; Cividalli G; Weshler Z; Weiss L; Mumcuoglu M; Engelhard D; Aker M; Pollack A
Isr J Med Sci; 1986; 22(3-4):264-7. PubMed ID: 3528046
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation in the rat. V. Lymphoid cell subclasses in the target organs during acute graft-versus-host disease.
Renkonen R
Transplantation; 1986 Jun; 41(6):704-8. PubMed ID: 2940737
[TBL] [Abstract][Full Text] [Related]
8. An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells.
Murphy WJ; Kumar V; Cope JC; Bennett M
J Immunol; 1990 May; 144(9):3305-11. PubMed ID: 2329274
[TBL] [Abstract][Full Text] [Related]
9. Booster irradiation to the spleen following total body irradiation. A new immunosuppressive approach for allogeneic bone marrow transplantation.
Lapidot T; Singer TS; Salomon O; Terenzi A; Schwartz E; Reisner Y
J Immunol; 1988 Oct; 141(8):2619-24. PubMed ID: 3049814
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow graft: graft versus host reaction and rejection].
Fischer A; Griscelli C
Nephrologie; 1986; 7(3 Suppl):1-4. PubMed ID: 3534616
[TBL] [Abstract][Full Text] [Related]
11. Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response.
Guillén FJ; Ferrara J; Hancock WW; Messadi D; Fonferko E; Burakoff SJ; Murphy GF
Lab Invest; 1986 Jul; 55(1):35-42. PubMed ID: 3523039
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic marrow transplantation after total lymphoid irradiation (TLI): effect of dose/fraction, thymic irradiation, delayed marrow infusion, and presensitization.
Gottlieb M; Strober S; Kaplan HS
J Immunol; 1979 Jul; 123(1):379-83. PubMed ID: 376743
[TBL] [Abstract][Full Text] [Related]
13. A subpopulation of asialo GM1-positive cells plays a protective role in the occurrence of graft-versus-host disease (GVHD) in mice.
De Ruysscher D; Sobis H; Vandeputte M; Waer M
Transplant Proc; 1991 Feb; 23(1 Pt 1):804. PubMed ID: 1824997
[No Abstract] [Full Text] [Related]
14. Engraftment following T cell-depleted bone marrow transplantation. III. Differential effects of increased total-body irradiation on semiallogeneic and allogeneic recipients.
Ferrara JL; Michaelson J; Burakoff SJ; Mauch P
Transplantation; 1988 May; 45(5):948-52. PubMed ID: 3285542
[TBL] [Abstract][Full Text] [Related]
15. Engraftment of allogeneic bone marrow cells: experimental investigations on the role of cell dose, graft-versus-host reactive T cells and pretransplant immunosuppression.
Uharek L; Glass B; Gassmann W; Eckstein V; Steinmann J; Loeffler H; Mueller-Ruchholtz W
Transplant Proc; 1992 Dec; 24(6):3023-5. PubMed ID: 1466042
[No Abstract] [Full Text] [Related]
16. Murine cytomegalovirus infection can enhance hybrid resistance through modulation of host natural killer activity.
Muluk SC; Hakim FT; Shearer GM
J Immunol; 1990 Aug; 145(4):1113-9. PubMed ID: 2166108
[TBL] [Abstract][Full Text] [Related]
17. A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts.
Yankelevich B; Knobloch C; Nowicki M; Dennert G
J Immunol; 1989 May; 142(10):3423-30. PubMed ID: 2654290
[TBL] [Abstract][Full Text] [Related]
18. [Host-graft interactions after allogenic bone marrow transplantation; choice of donor].
Alby N; Bernard A; Devergie A; Goldman JM; Hervé P; Maraninchi P; Raffoux C; Gluckman E
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):55-64. PubMed ID: 3290840
[TBL] [Abstract][Full Text] [Related]
19. Antilymphocytic antibodies and marrow transplantation. V. Suppression of secondary disease by host-versus-theta-graft reaction.
Thierfelder S; Rodt H
Transplantation; 1977 Jan; 23(1):87-92. PubMed ID: 319574
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum.
Oluwole SF; Engelstad K; Hardy MA
Transplant Proc; 1992 Dec; 24(6):2858-9. PubMed ID: 1465974
[No Abstract] [Full Text] [Related]
[Next] [New Search]
